The mRNA Assay Development Summit: Creating Better mRNA Drugs with Validated, Reliable & Reproducible Assays

Despite advancements and investments accelerating the development of mRNA therapies, there is still limited regulatory guidance. Developing standardized and sensitive assays to assess quality and stability still remains a key challenge.

Returning in December 2024, the mRNA Assay Development Summit will be the only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development. This unique forum will allow the field to develop a set of best practices to accelerate the movement of mRNA drugs through the clinic and to patients. 

40+ industry experts including Moderna, Sanofi, BioNTech and more will unite to address key bottlenecks in the field, ensuring robust and reproducible assay strategy to achieve regulatory compliance, fast-tracking mRNA therapeutics and vaccines into the clinic and towards approval.